First Trust Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.4M Sell
537,186
-387,131
-42% -$28.4M 0.03% 660
2025
Q1
$106M Sell
924,317
-139,805
-13% -$16M 0.09% 265
2024
Q4
$53.6M Sell
1,064,122
-254,015
-19% -$12.8M 0.05% 483
2024
Q3
$61M Sell
1,318,137
-203,471
-13% -$9.42M 0.06% 417
2024
Q2
$49.4M Sell
1,521,608
-317,204
-17% -$10.3M 0.05% 481
2024
Q1
$46.3M Buy
1,838,812
+1,691,804
+1,151% +$42.6M 0.05% 499
2023
Q4
$4.77M Buy
147,008
+61,826
+73% +$2.01M 0.01% 1285
2023
Q3
$2.32M Buy
85,182
+70,840
+494% +$1.93M ﹤0.01% 1622
2023
Q2
$319K Sell
14,342
-24,835
-63% -$553K ﹤0.01% 2231
2023
Q1
$849K Sell
39,177
-108,741
-74% -$2.36M ﹤0.01% 2010
2022
Q4
$3M Buy
147,918
+74,667
+102% +$1.52M ﹤0.01% 1503
2022
Q3
$1.88M Sell
73,251
-24,068
-25% -$617K ﹤0.01% 1708
2022
Q2
$2.31M Buy
97,319
+6,615
+7% +$157K ﹤0.01% 1661
2022
Q1
$2.04M Buy
90,704
+41,687
+85% +$939K ﹤0.01% 1767
2021
Q4
$971K Buy
49,017
+33,446
+215% +$663K ﹤0.01% 2070
2021
Q3
$306K Sell
15,571
-69,480
-82% -$1.37M ﹤0.01% 2383
2021
Q2
$1.87M Sell
85,051
-127,267
-60% -$2.8M ﹤0.01% 1835
2021
Q1
$5.05M Buy
212,318
+114,586
+117% +$2.73M 0.01% 1235
2020
Q4
$2.56M Sell
97,732
-46,110
-32% -$1.21M ﹤0.01% 1457
2020
Q3
$2.5M Sell
143,842
-15,467
-10% -$269K ﹤0.01% 1262
2020
Q2
$2.68M Buy
159,309
+101,230
+174% +$1.7M ﹤0.01% 1234
2020
Q1
$691K Sell
58,079
-189,444
-77% -$2.25M ﹤0.01% 1798
2019
Q4
$3M Buy
247,523
+198,126
+401% +$2.4M 0.01% 1335
2019
Q3
$698K Buy
49,397
+37,100
+302% +$524K ﹤0.01% 2001
2019
Q2
$137K Sell
12,297
-154,534
-93% -$1.72M ﹤0.01% 2383
2019
Q1
$1.96M Buy
+166,831
New +$1.96M ﹤0.01% 1566
2018
Q4
Sell
-76,108
Closed -$1.07M 2412
2018
Q3
$1.07M Buy
76,108
+2,456
+3% +$34.4K ﹤0.01% 1939
2018
Q2
$1.16M Sell
73,652
-56,514
-43% -$889K ﹤0.01% 1884
2018
Q1
$2.14M Sell
130,166
-18,099
-12% -$298K ﹤0.01% 1428
2017
Q4
$2.68M Sell
148,265
-57,547
-28% -$1.04M 0.01% 1342
2017
Q3
$3.97M Sell
205,812
-4,649
-2% -$89.7K 0.01% 1104
2017
Q2
$2.48M Buy
+210,461
New +$2.48M 0.01% 1346